Pokemon's cancer role revealed

Important new insights into neoplastic development provided by report in Nature

Written byMarta Paterlini
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) report in Nature this week that they have identified a new cellular oncogene.

The team led, by cancer geneticist Pier Paolo Pandolfi, showed for the first time that the so-called Pokemon gene—which shares a name with a Japanese cartoon popular with children—functions as a proto-oncogene repressing the tumor suppressor ARF.

"This is a very elegant paper," said Gary Gilliland, a Howard Hughes scholar at Harvard Medical School, who did not participate in the study. "The observations of Dr. Pandolfi and his colleagues provide new insights into mechanisms of tumorigenesis."

Gilliland noted that loss of function of critical tumor suppressors may occur through mutation or deletion and that decreased expression due to epigenetic modifications may also explain loss of function of tumor suppressors.

"Several lines of evidence in this report indicate that a novel mechanism of inhibition of expression of tumor suppressors, such as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies